Patent Box Tax Calculator

Patent Box: Full Expert Guide 2026

What Is the Patent Box?

The Patent Box is a UK corporation tax regime that taxes profits attributable to qualifying patented inventions at a reduced rate of 10% rather than the standard 19% or 25% rates. Introduced in 2013, it aims to encourage innovative companies to keep and commercialise their IP in the UK. The Patent Box is governed by Part 8A of the Corporation Tax Act 2010, as amended by Finance Act 2016 to align with OECD BEPS Action 5 (the "nexus approach").

In 2024/25, HMRC reported that over 1,400 companies claimed the Patent Box, generating a total tax saving of approximately £1.2 billion. The regime has been growing steadily as awareness increases, particularly among pharmaceutical, engineering, technology, and medical devices companies. The minimum financial benefit worth pursuing a Patent Box claim is typically where IP profits exceed £50,000–£100,000, making the compliance costs economical.

Qualifying IP for Patent Box

Only specific categories of intellectual property qualify for the Patent Box. The qualifying IP must be owned by the company or exclusively licensed in, and the company must have undertaken qualifying development in relation to it.

Qualifying Development Activity

To claim Patent Box, the company (or a member of its group) must have created the invention that is the subject of the patent, or made a significant contribution to the development or improvement of the patented product or process. Simply purchasing a patent and licensing it does not qualify without this development activity. "Significant contribution" is a qualitative test based on facts — contributing to the inventive concept is more relevant than the amount of R&D expenditure.

How the Calculation Works — The Standard Method

The Patent Box calculation uses a two-step process. First, the "relevant IP profits" (RIPP) are identified. Then the Patent Box deduction is computed to reduce the effective tax rate to 10%.

Step 1 — Identify Qualifying IP Income (QIPI): This includes sales of products incorporating the patented invention, licensing income from the patent, income from selling or disposing of the patent, and damages/compensation awards related to IP infringement.

Step 2 — Calculate Relevant IP Profits (RIPP): Apportion total trading profits by the ratio of QIPI to total income: RIPP = Total Profits × (QIPI / Total Income). Then deduct a "routine return" (10% of relevant IP costs) and a "marketing asset return" (notional royalty for brand/marketing value). Under the streaming method (mandatory for complex companies), each IP right is streamed separately.

Step 3 — Apply the Nexus Fraction: RIPP × Nexus Fraction = Patent Box eligible profits. The nexus fraction is: (D + S1) / (D + S1 + S2 + A), where D = own R&D costs; S1 = costs of outsourced R&D to unconnected parties; S2 = costs of outsourced R&D to connected parties; A = acquisition costs of IP. The nexus fraction prevents companies from claiming Patent Box on profits from IP that was substantially developed or acquired externally.

Step 4 — Calculate the Deduction: The deduction = Patent Box profit × (Standard rate − 10%) / Standard rate. This deduction is subtracted from the corporation tax computation, effectively bringing the rate on qualifying profits down to 10%.

Worked Example: £500,000 Total Profits, £200,000 IP Profits

Interaction with R&D Tax Credits

Patent Box and R&D tax credits (RDEC) can be claimed simultaneously for the same company — they are not mutually exclusive. The key interaction is the order in which they are applied: R&D relief is computed first and reduces taxable profits (or provides a cash credit). The Patent Box calculation then operates on the post-R&D profit figure. In practice, companies benefit from both regimes together: the R&D credit reduces the overall tax bill, and Patent Box reduces the rate on qualifying IP profits within the remaining taxable profits.

Example: A company has £1 million profit, £300,000 R&D expenditure (20% RDEC = £60,000 credit reduces tax), and £400,000 qualifying IP profits. The RDEC offsets the CT bill by £60,000, and Patent Box reduces the rate on the £400,000 from 25% to 10%, saving a further £60,000. Combined benefit: £120,000 in total tax savings.

Election Process and Timing

Patent Box election is included in the corporation tax return. The election must be made within 2 years of the end of the relevant accounting period. Once elected, it applies to all subsequent periods unless revoked. Revocation is not permitted within 5 years of an election. Companies should maintain detailed records of:

• IP portfolio with registration dates, grant dates, and country of registration
• Revenue streams attributable to each qualifying IP right
• R&D expenditure categorised by D/S1/S2/A (for nexus fraction)
• Development activity documentation demonstrating qualifying development
• Transfer pricing documentation for intra-group IP transactions

HMRC Clearances and Risk Reviews

Patent Box claims are not pre-approved by HMRC but can be subject to enquiry. For large or complex claims, companies may seek advance clearance through HMRC's non-statutory clearance procedure. HMRC's Large Business directorate operates a "real-time" working approach for companies with a Customer Compliance Manager (CCM), allowing Patent Box positions to be discussed and agreed before filing. HMRC's R&D and Innovation Unit handles specialist Patent Box and R&D credit reviews.

Key areas of HMRC scrutiny include: proper attribution of profits to qualifying IP (particularly in product companies where the patent covers only part of the product); the nexus fraction and documentation of R&D expenditure categories; the routine return deduction and marketing asset return calculations; and the validity of qualifying development activity for acquired patents.

BEPS Action 5 and Nexus Requirement

The UK Patent Box was revised from July 2021 to comply with OECD BEPS (Base Erosion and Profit Shifting) Action 5, which introduced the "nexus approach" for IP regimes. The nexus approach requires that the tax benefit from an IP regime is proportional to the R&D expenditure directly incurred by the company claiming the benefit. Companies that acquired patents from third parties (particularly group companies) face a reduced nexus fraction, limiting their Patent Box benefit to the proportion of qualifying R&D they performed directly. This prevents multinationals from buying patents and attributing profits to the Patent Box without genuine local R&D activity.

Pillar Two Interaction for Large Groups

The OECD Pillar Two global minimum tax (GloBE rules), effective for groups with consolidated revenue over €750 million from 1 January 2024, requires a minimum 15% effective tax rate per jurisdiction. The UK Patent Box reduces the effective rate on IP profits to 10% — below the 15% minimum. Large MNE groups may therefore face top-up taxes under the UK's Qualified Domestic Minimum Top-up Tax (QDMTT) to bring their effective rate up to 15% on Patent Box profits. Practically, this means the Patent Box benefit for affected large groups is reduced from 15% (25% − 10%) to approximately 10% (25% − 15%). For groups below the €750m threshold, Pillar Two does not apply and the full Patent Box benefit is retained.

Patent Box Strategy Tips

Sources & Methodology

This calculator uses the 10% Patent Box rate and 2025/26 standard corporation tax rates. The nexus fraction is user-defined. For companies in the marginal relief band, the applicable standard rate is approximate — use your actual effective rate from your tax computation.

Official References

• HMRC — Patent Box
• HMRC — Corporate Intangibles, Research and Development Manual (CIRD)
• Corporation Tax Act 2010, Part 8A — Patent Box
• HMRC — Corporation Tax Rates